Evotec AG has extended its research collaboration with Ono Pharmaceutical Co., Ltd. and initiated a new discovery alliance. Evotec will provide drug discovery activities, including high throughput screening, medicinal chemistry and in vitro pharmacology to discover small molecular weight compounds against an ion channel target selected by Ono. Ono will use Evotec’s ion channel drug discovery platform and expertise and in return, Evotec will receive research funding and milestone payments. ...